VEGFA and hepatocellular carcinoma: By analyzing the mechanism of immune combined with anti-angiogenic drugs, it was found that anti- Vascular endothelial growth factor (VEGF) therapy can reduce the effect of immunosuppression in hepatocellular carcinoma (HCC) and significantly improve the effect of therapy with immune checkpoint inhibitors (ICIs) [3,4].